Stock Track | Liquidia Technologies Soars 5% in Pre-Market on Strong Q4 Results, Revenue Beat and Return to Profitability

Stock Track

03/05

Liquidia Technologies Inc's stock surged 5.00% in pre-market trading following the release of its fourth quarter and full year 2025 financial results.

The company reported a significant swing to profitability in the fourth quarter, with net income of $14.6 million compared to a loss of $38.5 million in the same period last year. Revenue for the quarter reached $92.02 million, surpassing analyst consensus estimates of $87.49 million. This marks the company's second consecutive quarter of profitability since launching its YUTREPIA product.

Liquidia's CEO, Dr. Roger Jeffs, highlighted the strong commercial performance of YUTREPIA, which achieved net product sales of $148.3 million for the full year 2025, with $90.1 million coming in the fourth quarter alone. The company reported more than 3,600 unique prescriptions and over 2,900 patients treated since the product's launch in June 2025, indicating robust market adoption and growth trajectory.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1189821899"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1189821899\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1189821899?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-05 20:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1189821899","market":"nz","top_or_hot":-1,"title":"Stock Track | Liquidia Technologies Soars 5% in Pre-Market on Strong Q4 Results, Revenue Beat and Return to Profitability","media":"Stock Track","content":"<p>Liquidia Technologies Inc's stock surged 5.00% in pre-market trading following the release of its fourth quarter and full year 2025 financial results.</p><p>The company reported a significant swing to profitability in the fourth quarter, with net income of $14.6 million compared to a loss of $38.5 million in the same period last year. Revenue for the quarter reached $92.02 million, surpassing analyst consensus estimates of $87.49 million. This marks the company's second consecutive quarter of profitability since launching its YUTREPIA product.</p><p>Liquidia's CEO, Dr. Roger Jeffs, highlighted the strong commercial performance of YUTREPIA, which achieved net product sales of $148.3 million for the full year 2025, with $90.1 million coming in the fourth quarter alone. The company reported more than 3,600 unique prescriptions and over 2,900 patients treated since the product's launch in June 2025, indicating robust market adoption and growth trajectory.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Liquidia Technologies Soars 5% in Pre-Market on Strong Q4 Results, Revenue Beat and Return to Profitability</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Liquidia Technologies Soars 5% in Pre-Market on Strong Q4 Results, Revenue Beat and Return to Profitability\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2026-03-05 20:02</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Liquidia Technologies Inc's stock surged 5.00% in pre-market trading following the release of its fourth quarter and full year 2025 financial results.</p><p>The company reported a significant swing to profitability in the fourth quarter, with net income of $14.6 million compared to a loss of $38.5 million in the same period last year. Revenue for the quarter reached $92.02 million, surpassing analyst consensus estimates of $87.49 million. This marks the company's second consecutive quarter of profitability since launching its YUTREPIA product.</p><p>Liquidia's CEO, Dr. Roger Jeffs, highlighted the strong commercial performance of YUTREPIA, which achieved net product sales of $148.3 million for the full year 2025, with $90.1 million coming in the fourth quarter alone. The company reported more than 3,600 unique prescriptions and over 2,900 patients treated since the product's launch in June 2025, indicating robust market adoption and growth trajectory.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LQDA","symbol_name":"Liquidia Technologies Inc","start_time":0,"source_url":"","article_id":"1189821899","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1189821899","pubTimestamp":1772712162,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Liquidia Technologies Inc's stock surged 5.00% in pre-market trading following the release of its fourth quarter and full year 2025 financial results.The company reported a significant swing to...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LQDA":"Liquidia Technologies Inc"},"translate_title":"个股追踪|Liquidia Technologies盘前大涨5%，Q4业绩强劲，营收超预期并恢复盈利","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LQDA":1},"content_text":"Liquidia Technologies Inc's stock surged 5.00% in pre-market trading following the release of its fourth quarter and full year 2025 financial results.The company reported a significant swing to profitability in the fourth quarter, with net income of $14.6 million compared to a loss of $38.5 million in the same period last year. Revenue for the quarter reached $92.02 million, surpassing analyst consensus estimates of $87.49 million. This marks the company's second consecutive quarter of profitability since launching its YUTREPIA product.Liquidia's CEO, Dr. Roger Jeffs, highlighted the strong commercial performance of YUTREPIA, which achieved net product sales of $148.3 million for the full year 2025, with $90.1 million coming in the fourth quarter alone. The company reported more than 3,600 unique prescriptions and over 2,900 patients treated since the product's launch in June 2025, indicating robust market adoption and growth trajectory.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}